ADRENALINE AGUETTANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.1 MG/ML [SIN16897P]

Product Info

ADRENALINE AGUETTANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.1 MG/ML

[SIN16897P]

4.1. Therapeutic indications
Cardiopulmonary resuscitation
Acute anaphylaxis in adults

4.2. Posology and method of administration
Intravenous adrenaline should only be administered by those experienced in the use and titration of vasopressors in their normal clinical practice.

Cardiopulmonary resuscitation:
10 ml of the 0.1 mg/mL solution (1 mg) by the intravenous or intraosseous route, repeated every 3–5 minutes until return of spontaneous circulation.

Acute anaphylaxis
Titrate using intravenous boluses of 0.5 ml 0.1 mg/mL solution (0.05 mg) according to response.
ADRENALINE AGUETTANT solution for injection in pre-filled syringe 0.1 mg/mL is not recommended for intramuscular use in acute anaphylaxis. For intramuscular administration, a 1mg/ml solution should be used.

Paediatric Population:
This medicinal product is not appropriate to deliver a dose of less than 0.5 ml and should therefore not be used by the intravenous or intraosseous route, in neonates and infants with body weight less than 5 kg.

Cardiac arrest in children:
Intravenous or intraosseous route (above 5 kg only): 0.1 ml/kg of 0.1 mg/mL solution (10 micrograms/kg) to a maximum single dose of 10 ml of 0.1 mg/mL solution (1 mg), repeated every 3–5 minutes until return of spontaneous circulation.

4.3. Contraindications
Patients with known hypersensitivity to an excipient, where an alternative presentation of adrenaline or alternative vasopressor is available.